APYX MEDICAL CORPORATION

Analyst Reco. Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
1.32 ^USD	-4.35%		-9.59%	-49.62%

Apr. 05	Archon Capital Management Engages with Apyx Medical Corporation	CI
Apr. 01	Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Adjusts Price Target on Apyx Medical to $5 From $8, Keeps Overweight Rating	Nov. 10	MT
Stephens Initiates Apyx Medical With Overweight Rating, $8 Price Target	23-07-14	MT
Lake Street Raises Apyx Medical's Price Target to $9 From $6, Maintains Buy Rating	23-06-15	MT
Lake Street Adjusts Price Target on Apyx Medical to $6 From $5, Keeps Buy Rating	23-05-12	MT
Lake Street Assumes Apyx Medical at Buy Rating With $5 Price Target	22-12-08	MT
Piper Sandler Adjusts Price Target on Apyx Medical to $12 From $6, Reiterates Overweight Rating	22-08-12	MT
Lake Street Raises Apyx Medical's Price Target to $17 From $14, Maintains Buy Rating	22-07-19	MT
Lake Streets Initiates Apyx Medical at Buy, Sets Price Target at $12	22-05-20	MT
Piper Sandler Adjusts Apyx Medical's Price Target to $6 From $12, Reiterates Overweight Rating	22-05-13	MT
Piper Sandler Lowers Price Target for Apyx Medical to $12 From $20, Maintains Overweight Rating	22-03-17	MT
APYX MEDICAL : JMP Securities Adjusts Price Target on Apyx Medical to $14 From $12, Maintains Market Outperform Rating	21-08-13	MT
APYX MEDICAL : Piper Sandler Adjusts Apyx Medical PT to $12 From $8, Maintains Overweight Rating	21-01-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer